<DOC>
	<DOCNO>NCT00804258</DOCNO>
	<brief_summary>RATIONALE : Palliative care may help improve quality life patient ovarian cancer undergo intraperitoneal chemotherapy . PURPOSE : This clinical trial study palliative care patient ovarian cancer undergo intraperitoneal chemotherapy .</brief_summary>
	<brief_title>Palliative Care During Intraperitoneal Chemotherapy Patients With Ovarian Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Describe symptoms/concerns , , intraperitoneal ( IP ) chemotherapy impact symptoms/concerns quality life ( QOL ) patient ovarian cancer undergo IP chemotherapy . ( Part I ) - Analyze care receive resource utilization patient , include length hospitalization , ICU admission rate , clinic visit , phone call , urgent care visit , heath system encounter . ( Part I ) - Develop palliative care assessment measure intervention apply IP chemotherapy . ( Part II ) - Implement palliative care intervention pilot 6 patient . ( Part II ) - Describe impact implement palliative care intervention resource utilization , improve QOL symptom , number chemotherapy course complete . ( Part II ) OUTLINE : This two-part study . - Part I ( retrospective portion ) : Patients undergone intraperitoneal ( IP ) chemotherapy within past 6-12 month undergo retrospective interview chart audit identify need experience . - Part I ( prospective portion ) : Patients follow monthly 6 month IP chemotherapy provide information usual care identify need palliative care concern . Patients also complete quality-of-life ( QOL ) questionnaire ( COH QOL Ovarian tool ) undergo prospective interview . - Part II ( intervention ) : Patients undergo comprehensive palliative care assessment , patient teaching session prior initiation IP chemotherapy , palliative care intervention IP chemotherapy . Patients also complete QOL questionnaire undergo interview . Patients follow monthly 6 month IP chemotherapy .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis ovarian cancer Under care Medical Oncology Department City Hope National Medical Center Undergoing intraperitoneal chemotherapy PATIENT CHARACTERISTICS : Life expectancy &gt; 6 month Speaks English Spanish PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>recurrent ovarian epithelial cancer</keyword>
	<keyword>recurrent ovarian germ cell tumor</keyword>
	<keyword>stage I ovarian epithelial cancer</keyword>
	<keyword>stage I ovarian germ cell tumor</keyword>
	<keyword>stage II ovarian epithelial cancer</keyword>
	<keyword>stage II ovarian germ cell tumor</keyword>
	<keyword>stage III ovarian epithelial cancer</keyword>
	<keyword>stage III ovarian germ cell tumor</keyword>
	<keyword>stage IV ovarian epithelial cancer</keyword>
	<keyword>stage IV ovarian germ cell tumor</keyword>
</DOC>